SAB has entered into a definitive merger agreement with Big Cypress Acquisition Corp. (NASDAQ: BCYP) Click to Read More

Click for Webcast Replay

LEADERSHIP

Management Team

Eddie J. Sullivan, PhD
Co-Founder, President & CEO

Eddie Hamilton, DVM
Co-Founder, Executive Chairman BOD

Charles Randall, Jr.
Chief Strategy Officer

Tim Cunningham, CPA
Chief Financial Officer

Rick Finnegan
Chief Business Officer

Melissa Ullerich 
Chief Corporate Communications Officer

Christoph Bausch, PhD
Chief Science Officer

Kipp Erickson, PhD
Chief Operating Officer

Tom Luke, MD
Chief Medical Officer

Jerry Pommer, MSc, PAS, DACAWS
Chief Compliance Officer

Board of Directors

Eddie Hamilton, DVM
Co-Founder & Executive Chairman

David Link
Vice Chairman
Former Executive Vice President
Sanford Health

Eddie J. Sullivan, PhD
Co-Founder, President, CEO
SAB Biotherapeutics

Christine Hamilton
Co-Founder, SAB Biotherapeutics
Managing Partner, Christiansen Land & Cattle
Co-Owner BioDak, LLC

Bill Polvino, MD
CEO
Bridge Medicines

Mervyn Turner, PhD
Former Head of Strategy
Merck

Scientific Advisory Board

Jim Robl, PhD
Retired Biotechnology Executive & Professor

Scott A. Lesley, Ph.D.
Vice President, Discovery Biologics
Merck Research Laboratories

Arturo Casadevall, MD, PhD
Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases
Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine

Michael Haller, MD, MS–CI
Chief, Program Director, Pediatric Endocrinology and Professor
University of Florida Medical Center

Stephen E. Gitelman, MD
Professor of Clinical Pediatrics
KAK Distinguished Professor in Pediatric Diabetes and Clinical Research
University of California-San Francisco